Trial Profile
Planned study to investigate the efficacy of a wide range of doses of BLX 155 in patients with deep vein thrombosis.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2007
Price :
$35
*
At a glance
- Drugs BLX 155 (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 02 Aug 2007 New trial record.